Radio-theranostics: How Tiny Radioactive Molecules are Personalising Cancer Care The term 'theranostics' is an integration of the words 'therapeutics' and 'diagnostics'. Theranostic agents are paired agents, one an imaging agent th Read more
Metastasis directed Lu-177 PSMA Therapy in Prostate Cancer Patients with Oligometastatic Disease Oligometastatic prostate cancer (OMPC) that has five or fewer sites of metastasis is considered a transitional state between localized and widespread Read more
Is PRRT Right for You? Before we go on to discuss the above topic at hand, let me explain PRRT. In PRRT, a radiopeptide is created by combining a small amount of radioactive Read more
Medical Travel to India’s Fortis Memorial Research Institute, India – My Experience I am writing this blog to guide patients who would want to come to India for medical treatment. This is a step-by-step logistics guide and is entirely Read more
My Experience Getting Lu177 PSMA Therapy In India at Fortis Memorial Research Institute (FMRI) I am a Prostate Cancer patient from USA (name withheld on request). I came to India, specifically to the Department of Nuclear Medicine & Molecular Im Read more
TARE vs TACE for Hepatocellular Carcinoma and NET patients Transarterial Chemoembolisation or TACE has been the initial treatment modality for HCC and has a huge body of evidence from several studies and clini Read more
Use of Yttrium 90 (Y-90) and its effects Yttrium-90 or Y90is a commonly used isotope in the medical field specially in departments like nuclear medicine and radiation oncology for radiation t Read more
PRRT Treatment Day Overview This overview provides the patient and the caregiver a peek at what to expect during a typical PRRT treatment with Lu177 (Lutathera) and it covers the Read more
Lu177 PRRT For Neuroendocrine Tumors (Nets) PRRT or Peptide Receptor Radionuclide Therapy is a type of Nuclear Medicine Therapy in which a cell-targeting protein or peptide is combined with a sm Read more
Advancements in PRRT for treating Neuroendocrine tumours and other cancers. A look at Targeted Alpha The Neuroendocrine tumours (NETs) are heterogeneous with varying behaviour. Treatment decisions are taken basis Histological studies plus imaging data and Read more